The document, Governance arrangements for critical OTC derivatives data elements (other than UTI and UPI), identifies key criteria, functions and bodies for the governance arrangements for critical data.
The CPMI, IOSCO and the Financial Stability Board (FSB) have in recent years published reports to lay the foundation for the harmonisation work on key OTC derivatives data elements for meaningful aggregation on a global basis, including the 2014 FSB .
Following the feasibility study, the FSB asked the CPMI and IOSCO to develop global guidance on the harmonisation of data elements reported to TRs and important for the aggregation of data by authorities, including the Unique Transaction Identifier (UTI) and the Unique Product Identifier (UPI).
This consultative report is part of CPMI and IOSCO response to that mandate. It complements the Technical guidance on harmonisation of the UTITechnical guidance on harmonisation of the UPI Technical guidance on harmonisation of critical OTC derivatives data elements (other than UTI and UPI), the and the Technical guidance on harmonisation of critical OTC derivatives data elements (other than UTI and UPI)..
The report seeks general and specific comments from respondents by 27 September 2018.
Press release
Full consultation document
© IOSCO
Key
Hover over the blue highlighted
text to view the acronym meaning
Hover
over these icons for more information
Comments:
No Comments for this Article